Tirzepatide Personalized GLP-1 treatment for your weight and metabolic goals
doi: 10.3390/biom15010046 Summary Keywords type 2 diabetes mellitus, psoriasis, semaglutide, a case report, metabolic dysfunction-associated steatotic liver disease Citation Lin B, Huang Q, Weng L and Lin L (2025) Semaglutide in the treatment of a patient with type 2 diabetes mellitus, psoriasis, and metabolic dysfunction-associated steatotic liver disease: a case report
doi: 10.1016/j.ejphar.2022.175294 165 CryanJFORiordanKJCowanCSMSandhuKVBastiaanssenTFSBoehmeMet al
The most frequently reported side effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, which typically diminish over time as the body adjusts to treatment
When initiating combination therapy, the choice between simultaneous initiation and sequential add-on therapy remains a clinical consideration